Tau biomarkers in dementia: positron emission tomography radiopharmaceuticals in tauopathy assessment and future perspective

HIGHLIGHTS

  • who: Maria Ricci and collaborators from the Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy have published the article: Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective, in the Journal: (JOURNAL)
  • what: The authors provide an overview of first- and second-generation tracers used in ongoing clinical trials also describing the differences and the properties of novel tracers with a special focus on the distribution patterns of different Tau tracers.
  • future: Besides clinical support with the management of the patient a possible role . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?